NOMURA ASSET MANAGEMENT CO LTD

Position in ASND — Ascendis Pharma A/S

CIK 1055964 TOKYO, M0

Position in ASND

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$9,946,095

+$627,294 QoQ

Shares Held

43,484

-0.5% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 70.14199785767255.ToString("F0")% Shared 0.ToString("F0")% None 29.858002142327443.ToString("F0")%

Healthcare · as of Mar 31, 2026

NOMURA ASSET MANAGEMENT CO LTD holds $214,904,453 across 68 Biotechnology names. ASND ranks #6 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	121,167	$54,105,911
2	REGN	Regeneron Pharmaceuticals, Inc.	53,934	$41,671,564
3	ARGX	Argenx SE	49,306	$36,005,704
4	ALNY	Alnylam Pharmaceuticals, Inc.	93,225	$30,845,354
5	INSM	INSMED Inc	89,660	$14,661,203
6	ASND	Ascendis Pharma A/S This page	43,484	$9,946,095
7	RPRX	Royalty Pharma plc	171,980	$8,249,880
8	INCY	Incyte Corp	83,320	$7,842,077

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,946,095	43,484	-0.5%	Shares	Sole	2026-05-11
2025-12-31	$9,318,801	43,701	+57.5%	Shares	Sole	2026-02-10
2025-09-30	$5,517,176	27,751	+8.2%	Shares	Sole	2025-11-12
2025-06-30	$4,426,327	25,645	+20.4%	Shares	Sole	2025-08-11
2025-03-31	$3,320,129	21,302	+3.9%	Shares	Sole	2025-05-12
2024-12-31	$2,823,061	20,506	+13.9%	Shares	Sole	2025-02-12
2024-09-30	$2,687,580	18,000	+42.5%	Shares	Sole	2024-11-15
2024-06-30	$1,722,343	12,629	-9.3%	Shares	Sole	2024-08-14
2024-03-31	$2,105,646	13,929	+10.0%	Shares	Sole	2024-05-13
2023-12-31	$1,595,534	12,668	0.0%	Shares	Sole	2024-02-09
2023-09-30	$1,186,231	12,668	-12.1%	Shares	Sole	2023-11-03
2023-06-30	$1,286,271	14,412	—	Shares	Sole	2023-08-14
2020-09-30	$0	0	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.